EPIOXA HD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Epioxa Hd, and when can generic versions of Epioxa Hd launch?
Epioxa Hd is a drug marketed by Glaukos and is included in one NDA.
The generic ingredient in EPIOXA HD is riboflavin 5'-phosphate. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EPIOXA HD?
- What are the global sales for EPIOXA HD?
- What is Average Wholesale Price for EPIOXA HD?
Summary for EPIOXA HD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | EPIOXA HD at DailyMed |
US Patents and Regulatory Information for EPIOXA HD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaukos | EPIOXA HD/EPIOXA KIT | riboflavin 5'-phosphate | SOLUTION/DROPS;OPHTHALMIC | 219910-001 | Oct 17, 2025 | RX | Yes | Yes | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
